Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis

Journal of Gastroenterology

Volumn 41, Issue 6, 2006, Pages 540-546

  Yagi, Yuhki ^a   Andoh, Akira ^a   Inatomi, Osamu ^a   Bamba, Shigeki ^a   Tsujikawa, Tomoyuki ^a   Fujiyama, Yoshihide ^a   Mitsuyama, Keiichi ^b   Yoshida, Takashi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IBD; Inflammation; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; MESALAZINE; PREDNISOLONE;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKAPHERESIS; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; FEMALE; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; PLATELET AGGREGATION;

EID: 33746581214     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1797-y     Document Type: Article

References (33)

1. S Danese C de la Motte C Fiocchi 2004 Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications Am J Gastroenterol 99 938-45 15128364 10.1111/j.1572-0241.2004.04129.x
2. AS Weyrich GA Zimmerman 2004 Platelets: Signaling cells in the immune continuum Trends Immunol 25 489-95 15324742 1:CAS:528:DC%2BD2cXmvFWmu7s%3D 10.1016/j.it.2004.07.003
3. I Talstad K Rootwelt E Gjone 1973 Thrombocytosis in ulcerative colitis and Crohn's disease Scand J Gastroenterol 8 135-8 4697073 1:STN:280:CSyC2MrnsF0%3D
4. JW van Wersch P Houben J Rijken 1990 Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease J Clin Chem Clin Biochem 28 513-7 2258713 1:STN:280:By6D2sbnvFM%3D
5. AN Kapsoritakis MI Koukourakis A Sfiridaki SP Potamianos MG Kosmadaki IE Koutroubakis 2001 Mean platelet volume: A useful marker of inflammatory bowel disease activity Am J Gastroenterol 96 776-81 11280550 1:STN:280:DC%2BD3M7ovFOrsA%3D%3D 10.1111/j.1572-0241.2001.03621.x
6. R Quera F Shanahan 2004 Thromboembolism - an important manifestation of inflammatory bowel disease Am J Gastroenterol 99 1971-3 15447758 10.1111/ j.1572-0241.2004.40923.x
7. W Miehsler W Reinisch E Valic W Osterode W Tillinger T Feichtenschlager 2004 Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53 542-8 15016749 1:STN:280:DC%2BD2c7lvFWhsw%3D%3D 10.1136/gut.2003.025411
8. CE Collins MR Cahill AC Newland DS Rampton 1994 Platelets circulate in an activated state in inflammatory bowel disease Gastroenterology 106 840-5 8143990 1:STN:280:ByuC1M3psFM%3D
9. AA Vrij J Rijken JW Van Wersch RW Stockbrugger 2000 Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis Eur J Clin Invest 30 188-94 10691994 1:CAS:528:DC%2BD3cXitlSjs70%3D 10.1046/j.1365-2362.2000.00616.x
10. S Danese C de la Motte A Sturm JD Vogel GA West SA Strong 2003 Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients Gastroenterology 124 1249-64 12730866 1:CAS:528:DC%2BD3sXktVSktrs%3D 10.1016/S0016-5085(03)00289-0
11. S Danese JA Katz S Saibeni A Papa A Gasbarrini M Vecchi 2003 Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients Gut 52 1435-41 12970136 1:CAS:528:DC%2BD3sXotl2lu7c%3D 10.1136/gut.52.10.1435
12. A Andoh T Yoshida Y Yagi S Bamba K Hata T Tsujikawa K Kitoh M Sasaki Y Fujiyama 2006 Increased aggregation response of platelets in patients with inflammatory bowel disease J Gastroenterol 41 47-54 16501857 1:CAS:528:DC%2BD28XhvVWjsrs%3D 10.1007/s00535-005-1721-x
13. A Andoh T Tsujikawa K Hata Y Araki K Kitoh M Sasaki 2005 Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease Am J Gastroenterol 100 2042-8 16128950 1:CAS:528:DC%2BD2MXhtFWmsLzN 10.1111/j.1572-0241.2005.50381.x
14. K Yamaji K Yang H Tsuda H Hashimoto 2002 Fluctuations in sthe peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers Ther Apher 6 402-12 12460402 10.1046/j.1526-0968.2002.00459.x
15. T Hidaka K Suzuki Y Matsuki M Takamizawa-Matsumoto M Okada T Ishizuka 1999 Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis Ther Apher 3 178-85 10341394 1:STN:280:DyaK1M3nt12nsg%3D%3D 10.1046/j.1526-0968.1999.00136.x
16. Y Ueki S Yamasaki Y Kanamoto T Kawazu M Yano K Matsumoto 2000 Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis Rheumatology (Oxford) 39 165-71 1:STN:280:DC%2BD3c7ptVSnsA%3D%3D 10.1093/rheumatology/39.2.165
17. T Hidaka K Suzuki M Kawakami M Okada K Kataharada T Shinohara 2001 Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis J Clin Apher 16 74-81 11746532 1:STN:280:DC%2BD3MnpsFGjuw%3D%3D 10.1002/jca.1016
18. K Sawada K Ohnishi S Fukui K Yamada M Yamamura K Amano 1995 Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease J Gastroenterol 30 322-9 7647899 1:STN:280:ByqA2srovFM%3D 10.1007/BF02347507
19. K Sawada K Ohnishi T Kosaka S Chikano Y Yokota A Egashira 1997 Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis Ther Apher 1 207-11 10225739 1:STN:280:DyaK1M3ktValuw%3D%3D
20. K Nagase K Sawada K Ohnishi A Egashira K Ohkusu T Shimoyama 1998 Complications of leukocytapheresis Ther Apher 2 120-4 10225712 1:STN:280:DyaK1M3ktVansA%3D%3D
21. T Hibi T Yajima 1997 A novel therapy for corticosteroid-dependent or corticosteroid-resistant patients with ulcerative colitis Intern Med 36 317-8 9213164 1:STN:280:ByiA2Mnnt1w%3D
22. K Sawada T Muto T Shimoyama M Satomi T Sawada H Nagawa 2003 Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column Curr Pharm Des 9 307-21 12570823 1:CAS:528:DC%2BD3sXksl2nug%3D%3D 10.2174/1381612033391928
23. A Andoh A Ogawa K Kitamura O Inatomi S Fujino T Tsujikawa 2004 Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis J Gastroenterol 39 1150-7 15622478 1:CAS:528:DC%2BD2MXhtFSqsQ%3D%3D 10.1007/s00535-004-1464-0
24. A Andoh T Tsujikawa O Inatomi Y Deguchi M Sasaki H Obata 2005 Leukocytapheresis therapy modulates circulating T cell subsets in patients with ulcerative colitis Ther Apher Dial 9 270-6 15967005 1:CAS:528:DC%2BD2MXps1Kht7o%3D 10.1111/j.1774-9987.2005.00270.x
25. D Rachmilewitz 1989 Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial BMJ 298 82-6 2563951 1:STN:280:BiaC2M%2FntFA%3D
26. K Osumi Y Ozeki S Saito Y Nagamura H Ito Y Kimura 2001 Development and assessment of enzyme immunoassay for platelet-derived microparticles Thromb Haemost 85 326-30 11246556 1:CAS:528:DC%2BD3MXhvVKrsL0%3D
27. Y Kohgo T Ashida A Maemoto T Ayabe 2003 Leukocytapheresis for treatment of IBD J Gastroenterol 38 Suppl 15 51-4 12698872
28. M Noguchi N Hiwatashi T Hayakawa T Toyota 1998 Leukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: Role of bystander suppression Ther Apher 2 109-14 10225710 1:CAS:528:DyaK1cXjslGgurk%3D
29. K Mitsuyama A Suzuki S Matsumoto N Tomiyasu K Takaki H Takedatsu 2005 Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis Clin Exp Immunol 141 130-40 15958079 1:CAS:528:DC%2BD2MXms1ehs74%3D 10.1111/j.1365-2249.2005.02825.x
30. G Adamus 1985 Platelet aggregation GL Longenecker The platelets: physiology and pharmacology Academic New York 1-11
31. MJ Webberley MT Hart V Melikian 1993 Thromboembolism in inflammatory bowel disease: Role of platelets Gut 34 247-51 8432482 1:STN:280:ByyC283lsVQ%3D
32. CH Gemmell MV Sefton EL Yeo 1993 Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect J Biol Chem 268 14586-9 8325838 1:CAS:528:DyaK3sXlsFKqsr4%3D
33. S Nomura 2001 Function and clinical significance of platelet-derived microparticles Int J Hematol 74 397-404 11794694 1:STN:280:DC%2BD38%2FmslCgtA%3D%3D